CD38 is a multi‐functional extracellular enzyme with NADase and cyclase activities which regulates T‐cell functions by metabolising NAD and affecting NAD‐related enzymes such as SIRT1, which is also of interest in cancer biology58 and is a treatment target for multiple myeloma.59 This evidence concerns the gene SIRT1 and plasma cell myeloma.